MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-19-0037451
Tineta Pharma Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹119.85 Cr
▲ 17% YoY
Net profit · FY 2025
₹15.37 Cr
Net margin 12.8%
EBITDA · FY 2025
₹21.36 Cr
EBITDA margin 17.8%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹1.93 Cr
Issued & subscribed
Open charges
₹35 Cr
Satisfied ₹2.55 Cr
Company age
31 yrs
Est. 1995
Employees · EPFO
308
Provident fund records
About Tineta Pharma Private Limited
Data last updated:
Tineta Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the animal pharmaceuticals and healthcare segment of the pharmaceuticals sector. It was incorporated on 29 May 1995 and has been in existence for over 31 years.
Its director Sudhir Vijay Menon is #338 among India's richest people (2026). Its director Subodh Menon is #602 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1995PTC088871. Its GSTIN is 27AAACT3267F1ZE (Maharashtra).
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.93 Cr. It is led by directors including Subodh Vijayaraghava Menon and Perumangode Neelkandhan Ramaswamy.
Its last annual general meeting (AGM) was held on 10 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at G – 15/16 'Solaris – II' Premises Chs Ltd. Opp. L&T Gate 6 Saki Vihar Road Powai, Mumbai, Maharashtra, India – 400072.
As per the financials filed for FY 2025, the company reported a revenue of ₹119.85 Cr, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹15.37 Cr (net margin 12.8%) and EBITDA of ₹21.36 Cr (EBITDA margin 17.8%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 20% over five years.
The company has about 308 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Tineta Pharma. As per MCA filings, the company has open charges of ₹35 Cr and satisfied charges of ₹2.55 Cr on record. Court records list 49 cases involving the company, including 45 filed by the company and 4 filed against it; 7 cases are pending. The company has 7 deals on record (6 funding rounds, 1 secondary share transfer), with disclosed funding of ₹1.89 Cr; the latest was in March 2018. Its 6 peer companies in the Pharma industry (Animal Pharma), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 3 smaller; the largest is Vital Therapeutics Private Limited with revenue of ₹145.15 Cr. The company has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 9 overdue payments to 3 micro and small suppliers.
Tineta Pharma Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0037451). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website tineta.com.
Company details
CIN U24230MH1995PTC088871
Registration Number 088871
Incorporation Date 29 May 1995
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 10 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-19-0037451
Key People
Subodh Vijayaraghava Menon Director Perumangode Neelkandhan Ramaswamy Director Sudhir Vijay Menon Director Recognitions & Rankings of Tineta Pharma
India's Richest People 2026 edition · 2 directors · Source: Hurun India
- #338 Sudhir Vijay Menon ₹11,100 Cr
- #602 Subodh Menon ₹5,600 Cr
Contact details
Tineta Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is tineta.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressG – 15/16 'Solaris – II' Premises Chs Ltd. Opp. L&T Gate 6 Saki Vihar Road Powai, Mumbai, Maharashtra, India – 400072
- IndustryPharma, Animal Pharmaceuticals & Healthcare
To see the full contact details of Tineta Pharma Private Limited, buy the company report.
Comprehensive company report
Tineta Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Tineta Pharma operates one associated brand: Tineta Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures and supplies animal medicinal products and feed supplements for veterinary and agricultural use. | tineta.com |
Business activity
The main business activity of Tineta Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Tineta Pharma Private Limited, buy the company report.
Financials of Tineta Pharma Private Limited
FY 2025 filings availableTineta Pharma Private Limited reported revenue of ₹119.85 Cr (up 17% YoY) for FY 2025.
Revenue · FY 2025
₹119.85 Cr ▲ 17%
Net profit · FY 2025
₹15.37 Cr margin 12.8%
EBITDA · FY 2025
₹21.36 Cr margin 17.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 17%
3 years · compounded
▲ 14%
5 years · compounded
▲ 20%
EBITDA CAGR growth
1 year
▲ 108%
3 years · compounded
▲ 19%
5 years · compounded
▲ 74%
Revenue has grown at a compounded annual rate (CAGR) of 20% over five years, including 17% growth in the latest year. EBITDA rose 108% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹21.36 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹15.37 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17.8% | ||||
| Net Profit Margin | 12.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Tineta Pharma Private Limited, buy the company report.
Board of directors of Tineta Pharma Private Limited
Tineta Pharma has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Subodh Vijayaraghava Menon | Director | 15 Feb 2024 | 2 Years 8 Months | Current |
| Perumangode Neelkandhan Ramaswamy Also directs: Fobeoz India Private Limited, Dorf-Ketal Chemicals India Limited, Nayam Energy Private Limited and 5 more | Director | 15 Feb 2024 | 2 Years 8 Months | Current |
| Sudhir Vijay Menon | Director | 15 Feb 2024 | 2 Years 8 Months | Current |
Peer comparison
Tineta Pharma Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Animal Pharma), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vital Therapeutics Private Limited | ₹145.15 Cr (FY 2025) | -14.0% | Secunderbad, Telangana, India | |||
| Quadragen Vethealth Private Limited | ₹133.64 Cr (FY 2025) | -18.0% | Bangalore, Karnataka, India | |||
| Harshvardhans Laboratories Private Limited | ₹123.35 Cr (FY 2025) | 12.0% | Dhar, Madhya Pradesh, India | |||
| Tineta Pharma Private Limitedthis company | ₹119.85 Cr (FY 2025) | ₹15.37 Cr | 12.8% | 17.0% | 308 | Mumbai, Maharashtra, India |
| Panchsheel Organics Limited | ₹107.68 Cr (FY 2024) | 3.0% | Indore, Madhya Pradesh, India | |||
| Ayurvet Limited | ₹107.61 Cr (FY 2023) | 3.0% | Ahmedabad, Gujarat, India | |||
| Indovax Private Limited | ₹105 Cr (FY 2024) | 6.0% | New Delhi, Delhi, India |
To see the full peer comparison of Tineta Pharma Private Limited, buy the company report.
Auditor
Tineta Pharma Private Limited is audited by PRAKASH BAKHDA & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PRAKASH BAKHDA & ASSOCIATES | FY 2022 | 108070W |
Shareholding
The shareholding of Tineta Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Tineta Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹35 Cr
Satisfied charges
₹2.55 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Aug 2025 | 101155939 | Others | ₹35 Cr | Open | |
| 05 Oct 2011 | 10365377 | State Bank of India | ₹1 Cr | Satisfied | |
| 30 Jan 2006 | 80026055 | The Greater Bombay Co-Op Bank Ltd | ₹1.55 Cr | Satisfied |
To see the full charge records of Tineta Pharma Private Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Tineta Pharma Private Limited has 7 deals on record (6 funding rounds, 1 secondary share transfer), with disclosed funding of ₹1.89 Cr; the latest was in March 2018.
Total deals
7
Funding rounds
6
Secondary share transfer
1
Disclosed funding
₹1.89 Cr
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2018 | Secondary share transfer | Undisclosed | Buyer: Shreekant Pandurang Inamdar HUF Seller: 2 individuals |
| Mar 2016 | Funding round | ₹17.4 Lakh | Investors: Pradeep Verma HUF, Shreekant Pandurang Inamdar HUF, Vipin Chandan HUF, an individual |
| Mar 2015 | Funding round | ₹20.3 Lakh | Investors: Vipin Chandan HUF, Pradeep Verma HUF, 2 individuals |
| Feb 2013 | Funding round | ₹40.6 Lakh | Investors: Vipin Chandan HUF, Shreekant Pandurang Inamdar HUF, 2 individuals |
| Mar 2011 | Funding round | ₹36.9 Lakh | Investors: Shreekant Pandurang Inamdar HUF, Vipin Chandan HUF, Pradeep Verma HUF |
To see the full deal history of Tineta Pharma Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Tineta Pharma Private Limited has 49 court cases on record: 45 filed by Tineta Pharma, 4 filed against it. 7 cases are pending and 42 are disposed.
Total cases
49
Filed by the company
45
Filed against the company
4
Pending
7
Disposed
42
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 49 | 4 | 7 |
Cases on record (5 of 49)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed by the company against an individual | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed by the company against an individual | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed by the company against an individual | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed by the company against an individual | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed by the company against an individual | Pending |
To see the full case history of Tineta Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Tineta Pharma Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 9 overdue payments to 3 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (3 of 3)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| J Kantilal | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Tineta Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Tineta Pharma Private Limited has a workforce of 308 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
Employee count
308
Active EPFO establishments
1
Employee growth
14.5%
GST
Tineta Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACT3267F1ZE | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Tineta Pharma Private Limited, buy the company report.
Recent activity
Tineta Pharma Private Limited has 9 board changes on record since 2024: 3 appointments and 6 cessations. The latest: Perumangode Neelkandhan Ramaswamy ceased to be Additional Director on 27 Sep 2024.
AGM
Tineta Pharma Private Limited last Annual general meeting of members was held on 10 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 35.00 Cr with Charge ID 101155939 was registered on 28 Aug 2025.
Filing
Tineta Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Perumangode Neelkandhan Ramaswamy ceased to be Additional Director.
Ceased
Subodh Vijayaraghava Menon ceased to be Additional Director.
Ceased
Sudhir Vijay Menon ceased to be Additional Director.
Ceased
Pradeep Vidyasagar Verma ceased to be Director.
Ceased
Shreekant Pandurang Inamdar ceased to be Director.
Ceased
Vipin Volji Chandan ceased to be Whole-Time Director.
Appointed
Perumangode Neelkandhan Ramaswamy was appointed as Director.
Appointed
Subodh Vijayaraghava Menon was appointed as Director.
Appointed
Sudhir Vijay Menon was appointed as Director.
7 earlier events are in the company report.
Frequently asked questions
Tineta Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in animal pharmaceuticals and healthcare, within the pharma industry. It was incorporated on 29 May 1995 (31+ years old) and is registered under CIN U24230MH1995PTC088871.
Tineta Pharma has 3 current directors:
- Subodh Vijayaraghava Menon - Director
- Perumangode Neelkandhan Ramaswamy - Director
- Sudhir Vijay Menon - Director
The latest financial statements of Tineta Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 10 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Tineta Pharma is 27AAACT3267F1ZE, registered in Maharashtra.
The CIN (Corporate Identification Number) of Tineta Pharma is U24230MH1995PTC088871. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Tineta Pharma has 49 court cases on record: 45 filed by the company and 4 filed against it. 7 are pending.
Tineta Pharma was incorporated on 29 May 1995, making it 31+ years old. It is registered with the Registrar of Companies, Mumbai.
Tineta Pharma has 7 deals on record (6 funding rounds, 1 secondary share transfer), with disclosed funding of ₹1.89 Cr; the latest was in March 2018.
The peers of Tineta Pharma by revenue are Vital Therapeutics Private Limited, Quadragen Vethealth Private Limited, Harshvardhans Laboratories Private Limited, Panchsheel Organics Limited, Ayurvet Limited and 1 more, all in the Pharma industry (Animal Pharma), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Perumangode Neelkandhan Ramaswamy ceased to be Additional Director on 27 Sep 2024. Subodh Vijayaraghava Menon ceased to be Additional Director on 27 Sep 2024. Sudhir Vijay Menon ceased to be Additional Director on 27 Sep 2024. Tineta Pharma has 9 board changes on record in total.
Yes, Tineta Pharma is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-19-0037451).
Tineta Pharma has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 9 overdue payments to 3 micro and small suppliers. The latest return was filed on 26 Apr 2024.